Skip to main content
Clinical Trials/NCT02893072
NCT02893072
Unknown
Not Applicable

Individualized Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes

The Third Xiangya Hospital of Central South University1 site in 1 country600 target enrollmentNovember 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes, Gestational
Sponsor
The Third Xiangya Hospital of Central South University
Enrollment
600
Locations
1
Primary Endpoint
intravenous glucose
Last Updated
7 years ago

Overview

Brief Summary

Gestational diabetes mellitus (GDM) is one of the most frequent complications of pregnancy, that affect between 1 to 14% of population around the world. The overall purpose of this study is to determine the efficacy of individualized medical nutrition therapy (MNT) intervention to reduce and control the development of GDM.

Detailed Description

The number of women with gestational diabetes mellitus had been increasing. Maternal GDM has a great impact on both the health of the mothers and the offspring. Antenatal lifestyle interventions, in particular dietary intervention appear to be feasible to improve maternal GDM and weight gain. To the best of our knowledge, there has been no such trial examining the feasibility of MNT intervention in pregnant women in Hu'nan province. The aim of this study is to evaluate the efficacy of individualized MNT intervention to reduce and control the development of GDM. This is a prospective study, 500 patients who meet inclusion and exclusion criteria will be included. The changes of glucose and weight will be evaluated every two weeks.

Registry
clinicaltrials.gov
Start Date
November 2015
End Date
December 2020
Last Updated
7 years ago
Study Type
Interventional
Study Design
Single Group
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Women with gestational diabetes

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

intravenous glucose

Time Frame: every two weeks, from date of randomization until the date of parturition, assessed up to 10 months

Investigators will measure the participants' intravenous glucose every two weeks.From date of randomization until the date of parturition,assessed up to 10 months.

Study Sites (1)

Loading locations...

Similar Trials